User login
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study
Article Type
Changed
Thu, 01/10/2019 - 12:38
Display Headline
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study
Article PDF
Issue
Cutis - 83(6)
Publications
Page Number
299-302
Legacy Keywords
erythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Studyerythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Study, Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M
Article PDF
Article PDF
Issue
Cutis - 83(6)
Issue
Cutis - 83(6)
Page Number
299-302
Page Number
299-302
Publications
Publications
Article Type
Display Headline
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study
Display Headline
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study
Legacy Keywords
erythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Studyerythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Study, Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M
Legacy Keywords
erythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Studyerythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Study, Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M
Article Source
Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright
Inside the Article
Article PDF Media
Document